Dev Labtech Venture Plans ₹17.81 Crore Warrant Fundraise

Dev Labtech Venture Limited plans to raise ₹17.81 crore through 1.37 crore preferential convertible warrants priced at ₹13 each, subject to shareholder and regulatory approvals. The proposed warrants can convert into equity shares within 18 months of allotment, while shareholders were asked to consider the proposal at an Extraordinary General Meeting scheduled for November 5, 2026.

What did Dev Labtech Venture's board approve?

Dev Labtech Venture's board approved a proposal on October 7, 2026, to issue up to 1,37,00,000 convertible warrants on a preferential basis. The warrants are proposed to be allotted to promoter or promoter-group entities as well as non-promoter entities, at an issue price of ₹13 per warrant.

At the proposed price, the issue aggregates to ₹17.81 crore. The board also approved a proposal to increase the company's authorised share capital from ₹25 crore to ₹31 crore, subject to shareholder approval and the required regulatory processes. The authorised equity-share limit would rise from 5 crore shares of ₹5 face value each to 6.20 crore shares.

The company made the disclosures under Regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations. The proposal is structured as a preferential issue, meaning the securities are to be issued to identified categories of investors rather than through a public offering.

How will the convertible warrants work?

Each Dev Labtech Venture warrant is proposed to be convertible into one equity share with a face value of ₹5 and a premium of ₹8 per share. The conversion price is therefore ₹13 per equity share, matching the warrant issue price disclosed by the company.

The warrants carry an 18-month conversion period from their allotment date. Warrant holders must pay 25% of the issue price, or ₹3.25 per warrant, at the time of subscription. The remaining 75% is payable when the holder exercises the option to convert the warrants into equity shares.

If all 1.37 crore warrants are issued and subsequently converted, the company would issue an equal number of new equity shares. The actual conversion will depend on warrant holders exercising their conversion option within the stated period and complying with the approved terms.

Why is Dev Labtech Venture raising the funds?

Dev Labtech Venture has stated that the proposed funds will be used for the purchase of new land for business development and for general corporate purposes. The company has allocated ₹16.35 crore for the purchase of new land, with utilisation indicated within 24 months from receipt of the funds.

The land-acquisition component accounts for most of the proposed ₹17.81 crore mobilisation. The disclosure does not provide a location for the proposed land purchase or a detailed split of the amount earmarked for general corporate purposes.

The capital-raising proposal comes alongside the planned increase in authorised share capital. Increasing the authorised capital gives the company greater capacity to issue equity shares or convertible securities within the revised limit, subject to the approvals and procedures applicable to each issuance.

What approvals are required for the proposed issue?

The preferential issue requires shareholder approval through a special resolution at an Extraordinary General Meeting. Dev Labtech Venture scheduled the EGM for Thursday, November 5, 2026, at 1:00 pm through video conferencing or other audio-visual means.

The company set October 29, 2026, as the cut-off date for e-voting and appointed NSDL for the voting process. Shareholders were also asked to approve the increase in authorised share capital and the corresponding amendment to the Memorandum of Association.

The board approval alone does not complete the fundraise. The proposed allotment remains subject to the shareholder vote and applicable regulatory approval. The company has not disclosed completion of the warrant allotment in the information provided.

What does the proposal mean for investors and the company?

For Dev Labtech Venture, the transaction sets out a potential route to raise ₹17.81 crore without an immediate issue of all the underlying equity shares. However, conversion of the warrants would add up to 1.37 crore equity shares over the 18-month conversion window, which is relevant for shareholders assessing the potential expansion in the equity base.

The stated use of proceeds links the issue primarily to land purchase for business development. The company has not disclosed financial forecasts, expected returns from the land purchase, or a timetable beyond the indicated 24-month utilisation period for that allocation.

No share-price movement, valuation comparison, or market reaction was provided in the disclosures. Investors assessing the proposal can focus on the shareholder resolution, the identities and terms applicable to allottees as disclosed in the EGM notice, the eventual allotment status, and progress in deploying the funds for the stated purposes.

Conclusion

Dev Labtech Venture has proposed a ₹17.81 crore preferential fundraise through 1.37 crore convertible warrants at ₹13 each, paired with an increase in authorised share capital to ₹31 crore. The proposal provides funding for new land and general corporate purposes, while the warrant structure allows conversion into equity shares over an 18-month period.

The next disclosed milestone was the shareholder vote at the November 5, 2026 EGM. Investors should watch for the voting outcome, regulatory clearance, any final allotment disclosure, and subsequent updates on the planned ₹16.35 crore land purchase within the stated 24-month utilisation period.